Science Market Update

Stony Brook Lyme Disease Vaccine Shows Promise in Clinical Trials

Posted by Jennifer Nieuwkerk on Mon, Aug 26, 2013

Clinical trials were recently conducted and proved promising for a Lyme Disease vaccine developed by science researchers at Stony Brook University. The vaccine proved to produce a large number of antibodies against all targeted species of Borrelia, which causes Lyme Disease in Europe and the United States. Baxter International S.A., who worked with Stony Brook University researchers to develop the vaccine, conducted the clinical trials.

“After a series of experimentations and refinements, formulations consisting of these new OspA proteins were shown to protect against a broad spectrum of Lyme disease spirochetes,” said Dr. Luft, a co-author on the paper.

According to a Stony Brook University news article, Dr. Luft, also the Edmund D. Pellegrino Professor of Medicine at Stony Brook University, has been working with the late John Dunn, Ph.D. since the 1990s to develop the original vaccine antigen concept. Researchers at Baxter helped Dr. Luft to bioengineer the exact vaccine that was tested in the clinical trials.

“The results of the clinical trial conducted by Baxter are promising because the vaccine generated a potent human immune reaction, covered the complete range of Borrelia active in the entire Northern hemisphere, and produced no major side effects,” said Dr. Luft. “We hope that a larger-scale, Phase 3 trial will demonstrate not only a strong immune response but true efficacy in a large population that illustrates protection against Lyme disease.”


Dr. Luft

Dr. Luft

Image courtesy of Stony Brook University


In addition to conducting significant studies and clinical trials in the life sciences, Stony Brook University receives a wealth of NIH and NSF funding that may interest lab suppliers marketing life science products and making laboratory sales. In 2012, the NIH awarded Stony Brook University $59.3 million in research funding. For a full list of departments receiving funding, organized by department name, number of awards received and total funding awarded, please visit the NIH website.

Stony Brook University also received $22.1 million from the NSF in 2012. The research funding was given out to projects in various life science disciplines. For a full list of projects in life science fields receiving funding, organized by funding organization, project title and total funding awarded, please visit the NSF website.

If you are a lab supplier interested in marketing university life science products and making laboratory sales at Stony Brook University life science marketing events, Biotechnology Calendar, Inc. invites you to exhibit at our Stony Brook BioResearch Product Faire™ Event on October 3rd, 2013. Last year, the Stony Brook BioResearch Product Faire™ attracted 186 attendees. Forty-two of the attendees were purchasing agents, professors and post docs, and 18 were lab managers. The visitors came from 16 different research buildings and 28 departments around campus.

Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that has been organizing university life science marketing events across the country for 20 years. If you are interested in marketing your life science products and making laboratory sales at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more information on our Stony Brook BioResearch Product Faire™ Event, or to view more detailed funding statistics on Stony Brook University, click on the button below.

Click me

Tags: 2014, 2013, Northeast, Lyme Disease, vaccine, New York, Stony Brook University, BioResearch Product Faire Event, NY, Stony Brook, research news, SunySB

Subscribe to Company News